Log on / register
Feedback | Support | My details
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy.
Yee C
J Transl Med 2005 Apr 28, 3:17
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response.
Wang LX, Shu S, Disis ML, Plautz GE
Blood 2007 Jun 1, 109:4865-76
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.